Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sacconi

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Head & Neck|December 24, 2014
MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinomaFederica Ganci, Andrea Sacconi, Valentina Manciocco, et al.
Oncotarget|July 2, 2014
Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cellsMario Cioce, MariaCristina Valerio, Luca Casadei, et al.
International Journal of Molecular Sciences|January 21, 2023
Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like CellsValentina Dini, Giuseppe Esposito, Andrea Sacconi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2018
hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic processFrancesca Di Modugno, Valentina Caprara, Lidia Chellini, et al.
Clinical Pharmacokinetics|March 11, 2009
Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic functionAlessandra Felici, Susanna Di Segni, Michele Milella, et al.
Cell Death & Disease|January 5, 2023
Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibitionPiera Tocci, Celia Roman, Rosanna Sestito, et al.
Oncotarget|December 18, 2015
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinomaRosanna Sestito, Roberta Cianfrocca, Laura Rosanò, et al.
Computational and Structural Biotechnology Journal|August 19, 2022
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?Mario Cioce, Andrea Sacconi, Sara Donzelli, et al.
Molecular Cancer|November 29, 2023
Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patientsAndrea Sacconi, Paola Muti, Claudio Pulito, et al.
Oncotarget|March 12, 2016
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effectsFederica Mori, Maria Ferraiuolo, Raffaela Santoro, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Head & Neck|December 24, 2014
MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinomaFederica Ganci, Andrea Sacconi, Valentina Manciocco, et al.
Oncotarget|July 2, 2014
Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cellsMario Cioce, MariaCristina Valerio, Luca Casadei, et al.
International Journal of Molecular Sciences|January 21, 2023
Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like CellsValentina Dini, Giuseppe Esposito, Andrea Sacconi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2018
hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic processFrancesca Di Modugno, Valentina Caprara, Lidia Chellini, et al.
Clinical Pharmacokinetics|March 11, 2009
Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic functionAlessandra Felici, Susanna Di Segni, Michele Milella, et al.
Cell Death & Disease|January 5, 2023
Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibitionPiera Tocci, Celia Roman, Rosanna Sestito, et al.
Oncotarget|December 18, 2015
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinomaRosanna Sestito, Roberta Cianfrocca, Laura Rosanò, et al.
Computational and Structural Biotechnology Journal|August 19, 2022
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?Mario Cioce, Andrea Sacconi, Sara Donzelli, et al.
Molecular Cancer|November 29, 2023
Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patientsAndrea Sacconi, Paola Muti, Claudio Pulito, et al.
Oncotarget|March 12, 2016
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effectsFederica Mori, Maria Ferraiuolo, Raffaela Santoro, et al.
Pageof 12